Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1621 to 1635 of 2188 results for guidelines

  1. Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control (CG33)

    This guideline has been updated and replaced by NICE guideline CG117.

    Withdrawn guideline

  2. Hypertension: management of hypertension in adults in primary care (CG34)

    This guideline has been updated and replaced by NICE guideline CG127.

    Withdrawn guideline

  3. Obesity prevention (CG43)

    This guideline has been updated and replaced by NICE guideline NG246.

    Withdrawn guideline

  4. Chronic obstructive pulmonary disease in over 16s: diagnosis and management (CG101)

    This guideline has been updated and replaced by NICE guideline NG115.

    Withdrawn guideline

  5. Weight management: lifestyle services for overweight or obese adults (PH53)

    This guideline has been updated and replaced by NICE guideline NG246.

    Withdrawn guideline

  6. Preventing excess weight gain (NG7)

    This guideline has been updated and replaced by NICE guideline NG246.

    Withdrawn guideline

  7. Weight management: lifestyle services for overweight or obese children and young people (PH47)

    This guideline has been updated and replaced by NICE guideline NG246.

    Withdrawn guideline

  8. Obesity: working with local communities (PH42)

    This guideline has been updated and replaced by NICE guideline NG246.

    Withdrawn guideline

  9. Intrapartum care for healthy women and babies (CG190)

    This guideline has been updated and replaced by the NICE guideline on intrapartum care (NG235).

    Withdrawn guideline

  10. Cox-II inhibitors for the treatment of osteoarthritis and rheumatoid arthritis (TA27)

    This guidance has been replaced by NICE guideline CG59 and NICE guideline CG79.

    Withdrawn guidance

  11. Docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer (TA26)

    This guidance has been replaced by NICE guideline CG24 [Replaced by NICE guideline CG121].

    Withdrawn guidance

  12. COVID-19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19 (ES27)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

    Withdrawn advice

  13. COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

    Withdrawn advice

  14. COVID-19 rapid evidence summary: Sarilumab for COVID-19 (ES34)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

    Withdrawn advice

  15. Pneumonia in adults: diagnosis and management (CG191)

    This guideline has been updated and replaced by NICE's guideline on pneumonia: diagnosis and management (NG250).

    Withdrawn guideline